The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks
Open accessAbstract
Methylxanthines are a group of phytochemicals derived from the purine base xanthine and obtained from plant secondary metabolism. They are unobtrusively included in daily diet in common products as coffee, tea, energetic drinks, or chocolate. Caffeine is by far the most studied methylxanthine either in animal or epidemiologic studies. Theophylline and theobromine are other relevant methylxanthines also commonly available in the aforementioned sources. There are many disseminated myths about methylxanthines but there is increased scientific knowledge to discuss all the controversy and promise shown by these intriguing phytochemicals. In fact, many beneficial physiologic outcomes have been suggested for methylxanthines in areas as important and diverse as neurodegenerative and respiratory diseases, diabetes or cancer. However, there have always been toxicity concerns with methylxanthine (over)consumption and pharmacologic applications. Herein, we explore the structure-bioactivity relationships to bring light those enumerated effects. The potential shown by methylxanthines in such a wide range of conditions should substantiate many other scientific endeavors that may highlight their adequacy as adjuvant therapy agents and may contribute to the advent of functional foods. Newly designed targeted molecules based on methylxanthine structure may originate more specific and effective outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 6×
“In fact, methylxanthine plasma concentrations reached through dietary intake should not have effective impact in the activity of phosphodiesterases and GABAA receptors, or calcium release [11,159,177].”
BackgroundInfluentialAdenosine 3‘,5‘-Phosphate in Biological Materials
Butcher, R. W., & Sutherland, E. W. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60316-3 · Cited by 2,077
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Effects of caffeine on human health
Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J., Hugenholtz, A., & Feeley, M. (2003) · Food Additives and Contaminants · doi:10.1080/0265203021000007840 · Cited by 1,199 · cited 6×
“Th s inhibition results increased rel ase of hormones, such as norepinephrine, dopami e and serotonin [133].”
BackgroundInfluentialAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Food sources and intakes of caffeine in the diets of persons in the United States
Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.10.027 · Cited by 681
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review
van Dam, R. M., & Hu, F. B. (2005) · JAMA · doi:10.1001/jama.294.1.97 · Cited by 662 · cited 1×
“Both coffee [286–294] and tea [295,296] regular consumption have been related with decreased type 2 diabetes mellitus incidence.”
BackgroundCaffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210215655 · Cited by 631 · cited 1×
“For instance, for caffeine the acute toxic level should be about 10 g/day, which would be comparable to drinking 100 cups of instant coffee [362].”
BackgroundDing, M., Bhupathiraju, S. N., Satija, A., van Dam, R. M., & Hu, F. B. (2014) · Circulation · doi:10.1161/circulationaha.113.005925 · Cited by 565 · cited 1×
“Moreover, epidemiologic studies have provided evidence of the cardioprotective actions of methylxanthine-containing beverages, in reducing the risk of coronary heart disease and stroke [263–265].”
BackgroundDing, M., Bhupathiraju, S. N., Chen, M., van Dam, R. M., & Hu, F. B. (2014) · Diabetes Care · doi:10.2337/dc13-1203 · Cited by 511 · cited 1×
“However, caffeine may not be the main bioactive compound present in these beverages that is responsible for such protective effects [294,297,298].”
BackgroundThe absolute bioavailability of caffeine in man
Blanchard, J., & Sawers, S. J. A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613933 · Cited by 378
Haskell, C. F., Kennedy, D. O., Wesnes, K. A., & Scholey, A. B. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2104-3 · Cited by 356
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334 · cited 1×
“It is important to notice that, in fact, individuals do vary in their sensitivity to methylxanthines, and some of those fluctuations may be genetically originated [363–365].”
BackgroundLu, Y.-P., Lou, Y.-R., Xie, J.-G., Peng, Q.-Y., Liao, J., Yang, C. S., Huang, M.-T., & Conney, A. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182429899 · Cited by 316
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Glade, M. J. (2010) · Nutrition · doi:10.1016/j.nut.2010.08.004 · Cited by 306
Weng, X., Odouli, R., & Li, D.-K. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.803 · Cited by 279
Pharmacokinetics and metabolism of natural methylxanthines in animal and man
Arnaud, M. J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_3 · Cited by 259
Smoking, alcohol, and coffee consumption preceding Parkinson’s disease: A case-control study
Benedetti, M. D., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000) · Neurology · doi:10.1212/wnl.55.9.1350 · Cited by 234 · cited 1×
“Regarding Parkinson’s disease, both animal [217,231,232] and epidemiologic [218,233–238] studies have also hinted a link between midlife coffee/caffeine consumption and lower disease incidence.”
Backgroundvan Gelder, B. M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602495 · Cited by 228
Rogers, P. J., Hohoff, C., Heatherley, S. V., Mullings, E. L., Maxfield, P. J., Evershed, R. P., Deckert, J., & Nutt, D. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.71 · Cited by 212
Metabolic, catecholamine, and endurance responses to caffeine during intense exercise
Jackman, M., Wendling, P., Friars, D., & Graham, T. E. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.4.1658 · Cited by 207
Coffee Consumption and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies
Larsson, S. C., & Orsini, N. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr226 · Cited by 196 · cited 1×
“Moreover, epidemiologic studies have provided evidence of the cardioprotective actions of methylxanthine-containing beverages, in reducing the risk of coronary heart disease and stroke [263–265].”
BackgroundCaffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189 · cited 1×
“However, protection against blood-brain barrier dysfunction may represent a supplementary action justifying such beneficial effects [221,222].”
BackgroundCaffeine and risk of Parkinson’s disease in a large cohort of men and women
Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182 · cited 1×
“Regarding Parkinson’s disease, both animal [217,231,232] and epidemiologic [218,233–238] studies have also hinted a link between midlife coffee/caffeine consumption and lower disease incidence.”
BackgroundCoffee Consumption and Cognitive Function among Older Adults
Johnson-Kozlow, M. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf119 · Cited by 173 · cited 1×
“Epidemiologic studies seem to confirm a relationship between regular midlife caffeine/coffee consumption and a decreased risk of developing Alzheimer’s disease [214,216,227–230].”
BackgroundMerighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Simioni, C., Leung, E., Maclennan, S., Baraldi, P. G., & Borea, P. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032920 · Cited by 156
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
Schwabe, U., Ukena, D., & Lohse, M. J. (1985) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00572436 · Cited by 153
Caffeine attenuates scopolamine-induced memory impairment in humans
Reidel, W., Hogervorst, E., Leboux, R., Verhey, F., van Praag, H., & Jolles, J. (1995) · Psychopharmacology · doi:10.1007/bf02246090 · Cited by 152
Bech, B. H., Obel, C., Henriksen, T. B., & Olsen, J. (2007) · BMJ · doi:10.1136/bmj.39062.520648.be · Cited by 135
Rieg, T., Steigele, H., Schnermann, J., Richter, K., Osswald, H., & Vallon, V. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080432 · Cited by 133
Antagonism by theophylline of respiratory inhibition induced by adenosine
Eldridge, F. L., Millhorn, D. E., & Kiley, J. P. (1985) · Journal of Applied Physiology · doi:10.1152/jappl.1985.59.5.1428 · Cited by 110
Bidel, S., Hu, G., Qiao, Q., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2006) · Diabetologia · doi:10.1007/s00125-006-0435-9 · Cited by 107
Tea consumption and risk of type 2 diabetes: a dose–response meta-analysis of cohort studies
Yang, W.-S., Wang, W.-Y., Fan, W.-Y., Deng, Q., & Wang, X. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003887 · Cited by 103
Fatal Caffeine Intoxication: A Series of Eight Cases from 1999 to 2009
Banerjee, P., Ali, Z., Levine, B., & Fowler, D. R. (2014) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12387 · Cited by 93
Theanine and caffeine content of infusions prepared from commercial tea samples
Csupor, D., Boros, K., & Jedlinszki, N. (2016) · Pharmacognosy Magazine · doi:10.4103/0973-1296.176061 · Cited by 68 · cited 1×
“However, a very recent study by Boros and co-workers reported that caffeine content in commercial teas (white, green, oolong, black, and pu-erh) does not significantly differ according to the processing methods [45].”
BackgroundStudy, T. N. B. D. P., Hoyt, A. T., Browne, M., Richardson, S., Romitti, P., & Druschel, C. (2014) · Maternal and Child Health Journal · doi:10.1007/s10995-013-1397-4 · Cited by 58
Tajima, Y. (2010) · Clinical Medicine Insights: Case Reports · doi:10.4137/ccrep.s4329 · Cited by 22
Cited by
The new challenge of green cosmetics: natural food ingredients for cosmetic formulations
Dini, I., & Laneri, S. (2021) · Molecules · doi:10.3390/molecules26133921 · Cited by 217
Coffee and caffeine intake and male infertility: a systematic review
Ricci, E., Viganò, P., Cipriani, S., Somigliana, E., Chiaffarino, F., Bulfoni, A., & Parazzini, F. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0257-2 · Cited by 155
Porto, A. A., Valenti, V. E., Tonon do Amaral, J. A., Benjamim, C. J. R., Garner, D. M., & Ferreira, C. (2021) · Journal of the American College of Nutrition · doi:10.1080/07315724.2020.1768175 · Cited by 13
Metadata
- Authors
- Monteiro, J., Alves, M., Oliveira, P., & Silva, B.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2016-07-27
- Volume
- 21
- Issue
- 8
- Pages
- 974
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2494704835
- Cited by
- 182
- References
- 41
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.